The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome
- 2 November 2023
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (3) , 333-341
Abstract
Aims The no-reflow phenomenon (NRP) is a common complication of saphenous vein graft (SVG) interventions. The aim of this study was to investigate the effect of the stress hyperglycemia ratio (SHR) on the development of NRP in patients with acute coronary syndrome (ACS) undergoing percutaneous SVG intervention. Methods The study included 223 patients who presented at our center with ACS, had a history of coronary artery bypass graft and underwent a saphenous graft procedure. The relationship between SHR calculated at the time of presentation from glucose and HbA1c values, and the development of NRP evaluated after the procedure with angiography was determined with univariate and multivariate binary regression analysis. Result The study population was separated into two groups as those who developed and did not develop NRP. Mean age was determined to be significantly higher in the group that did not develop NRP compared to the group with NRP (p: 0.004). Angiographically, the thrombus burden was determined to be significantly higher in the group that developed NRP (p < 0.001). Patients were separated into 3 tertiles according to the SHR level (T1, T2, T3), and the rate of NRP development was determined at a significantly higher rate in the T3 group (p < 0.001). Conclusions This study showed that SHR, a parameter that can be easily calculated noninvasively, is an independent predictor of NRP development in ACS patients undergoing saphenous interventions. In addition, high thrombus burden and predilatation before stenting were also found to be factors that increase the likelihood of developing NRP.Keywords
This publication has 35 references indexed in Scilit:
- Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The HORIZONS-AMI trialInternational Journal of Cardiology, 2013
- Saphenous Vein Graft Failure After Coronary Artery Bypass SurgeryAnnals of Surgery, 2013
- Saphenous Vein Graft InterventionJACC: Cardiovascular Interventions, 2011
- Relation of Circulating Osteoprotegerin Levels on Admission to Microvascular Obstruction After Primary Percutaneous Coronary InterventionThe American Journal of Cardiology, 2011
- Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparisonAmerican Heart Journal, 2009
- Reperfusion Strategies in Acute ST-Elevation Myocardial Infarction: An Overview of Current StatusProgress in Cardiovascular Diseases, 2008
- Clinical and Procedural Predictors of No-Reflow Phenomenon After Primary Percutaneous Coronary Interventions Experience at a Single CenterCirculation Journal, 2008
- Impact of Admission Hyperglycemia and Diabetes Mellitus on Short- and Long-Term Mortality After Acute Myocardial Infarction in the Coronary Intervention EraThe American Journal of Cardiology, 2007
- Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graftAmerican Heart Journal, 2003
- PREVALENCE AND RISKS OF HYPERGLYCAEMIA AND UNDIAGNOSED DIABETES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1984